AI assistant
Sending…
XBiotech Inc. — Director's Dealing 2018
Jun 21, 2018
34229_dirs_2018-06-21_364f8b47-5431-4ba1-8273-da5fead58c08.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2018-06-19
Reporting Person: MCKENZIE W THORPE (Director, 10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-06-19 | Stock Option | $4.44 | A | 25000 | Acquired | 2028-06-19 | Common Stock (25000) | Direct |
More from XBiotech Inc.
Interim / Quarterly Report
2026
May 14
Annual Report
2026
Apr 29
Major Shareholding Notification
2026
Jan 23
Major Shareholding Notification
2026
Jan 23
Regulatory Filings
2025
Dec 9
Interim / Quarterly Report
2025
Nov 12
Director's Dealing
2025
Nov 12
Director's Dealing
2025
Nov 12
Director's Dealing
2025
Nov 12
Director's Dealing
2025
Nov 12